Skip to content

Bruxism and temporomandibular disorders in patients with Parkinson*s disease

Bruxism and temporomandibular disorders in patients with Parkinson*s disease - Parkinson's disease, bruxism and TMD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56565
Enrollment
470
Registered
2024-01-25
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporomandibular disorders

Interventions

None listed

Sponsors

Academisch Centrum Tandheelkunde Amsterdam (ACTA)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who fulfil the clinical diagnostic criteria for PD. - Adults (>18 years old)

Exclusion criteria

Exclusion criteria: - Children or adolescents (

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: the primary study parameters are the presence of bruxism, and a TMD diagnosis, according to the Diagnostic Criteria for TMD.

Secondary

MeasureTime frame
The following variables will be evaluated: Medication (viz., Levodopa Equivalent Daily Dose (LEDD)), pain (viz., pain severity), psychosocial symptoms (viz., depression, apathy, anxiety, psychotic, impulse control, somatic symptoms), brain function (viz., cognitive function, presynaptic dopaminergic loss), disease progression (viz., disease stage, disease severity), sleep (viz., quality of sleep, REM sleep behaviour disorder, OSAS) and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)